HUM vs UNH
Humana and UnitedHealth Group, both Healthcare
UnitedHealth Group is the larger company at $364B against $43B. On trailing earnings UNH is the cheaper of the two at a P/E of 25.8 against 41.7, a gap that is only a bargain if the two are growing at similar rates. Over the past year UNH returned +68% against +54% for HUM. Ryufin's sector-relative Smart Score puts HUM ahead, 6/10 against 5/10.
| Figure | HUM | UNH |
|---|---|---|
| Last close | $391 | $401 |
| Market cap | $43B | $364B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 41.7 | 25.8 |
| Dividend yield | 0.9% | 2.2% |
| 1-year return | +54% | +68% |
| 5-year return | -3.7% | +6.2% |
| Ryufin Smart Scoresector-relative, 1–10 | 6/10 | 5/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Humana
Revenue of $40B in Q1 2026, net income $1.2B. Its largest reported line is Center Well, 85% of the disclosed total.
UnitedHealth Group
Revenue of $112B in Q2 2026, net income $5.5B. Its largest reported line is Total Optum, 50% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.